List of works - Mathieu F. Chevalier

CD4 T-Cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus Burden

scientific article published on 29 September 2016

Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy

scientific article published on 19 July 2018

Distance to native climatic niche margins explains establishment success of alien mammals ⬇️

scientific article

Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functions

scientific article

HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function

scientific article

High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools

scientific article

ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

scientific article published on 26 June 2017

Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.

scientific article

Immunotherapeutic strategies for bladder cancer

scientific article published on 02 January 2014

Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.

scientific article

Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model

scientific article published on 29 January 2019

Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection

scientific article

Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor

scientific article published on 22 May 2015

Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells

scientific article published on 3 October 2014

Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.

scientific article published on 7 December 2016

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

scientific article published on 2 November 2015

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection

scientific article published on July 2014

The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation

scientific article

The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

scientific article published on 13 September 2012

The multifaceted immune regulation of bladder cancer

scientific article published on 09 September 2019

The pro- and anti-tumor role of ILC2s

scientific article published on 01 February 2019

The split personality of regulatory T cells in HIV infection

scientific article published on 04 October 2012

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

scientific article published on 19 September 2017

Using a robust multi‐settings inference framework on published datasets still reveals limited support for the abundant centre hypothesis: More testing needed on other datasets

scientific article published on 30 August 2021

γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activation

scientific article published on 01 July 2019

List of works by Mathieu F. Chevalier

CD4 T-Cell Responses in Primary HIV Infection: Interrelationship with Immune Activation and Virus Burden

Conventional and PD-L1-expressing Regulatory T Cells are Enriched During BCG Therapy and may Limit its Efficacy

Distance to native climatic niche margins explains establishment success of alien mammals ⬇️

Epithelial adhesion molecules can inhibit HIV-1-specific CD8⁺ T-cell functions

HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function

High-throughput monitoring of human tumor-specific T-cell responses with large peptide pools

ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence.

Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.

Immunotherapeutic strategies for bladder cancer

Interleukin-1 receptor antagonist, a biomarker of response to anti-TB treatment in HIV/TB co-infected patients.

Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell-Mediated Tumor Regression in the MB49 Bladder Cancer Model

Level of double negative T cells, which produce TGF-β and IL-10, predicts CD8 T-cell activation in primary HIV-1 infection

Local Salmonella immunostimulation recruits vaccine-specific CD8 T cells and increases regression of bladder tumor

Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells

Preclinical efficacy and safety of the Ty21a vaccine strain for intravesical immunotherapy of non-muscle-invasive bladder cancer.

Rosuvastatin Is Effective to Decrease CD8 T-Cell Activation Only in HIV-Infected Patients With High Residual T-Cell Activation Under Antiretroviral Therapy

T-cell activation positively correlates with cell-associated HIV-DNA level in viremic patients with primary or chronic HIV-1 infection

The Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocation

The early Th17/Treg ratio predicts the immune activation set point in patients with primary HIV infection

The multifaceted immune regulation of bladder cancer

The pro- and anti-tumor role of ILC2s

The split personality of regulatory T cells in HIV infection

Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis

Using a robust multi‐settings inference framework on published datasets still reveals limited support for the abundant centre hypothesis: More testing needed on other datasets

γδ T-cell subsets in HIV controllers: potential role of Tγδ17 cells in the regulation of chronic immune activation